- Home
- HYFM vs CLNN Comparison
HYFM vs CLNN Comparison
Compare HYFM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- CLNN
- Stock Information
- Founded
- HYFM 1977
- CLNN 2012
- Country
- HYFM United States
- CLNN United States
- Employees
- HYFM N/A
- CLNN N/A
- Industry
- HYFM Industrial Machinery/Components
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- CLNN Health Care
- Exchange
- HYFM Nasdaq
- CLNN Nasdaq
- Market Cap
- HYFM 38.1M
- CLNN 43.0M
- IPO Year
- HYFM 2020
- CLNN N/A
- Fundamental
- Price
- HYFM $0.61
- CLNN $4.68
- Analyst Decision
- HYFM Hold
- CLNN Strong Buy
- Analyst Count
- HYFM 2
- CLNN 4
- Target Price
- HYFM $0.70
- CLNN $55.25
- AVG Volume (30 Days)
- HYFM 114.8K
- CLNN 69.1K
- Earning Date
- HYFM 02-27-2025
- CLNN 03-12-2025
- Dividend Yield
- HYFM N/A
- CLNN N/A
- EPS Growth
- HYFM N/A
- CLNN N/A
- EPS
- HYFM N/A
- CLNN N/A
- Revenue
- HYFM $200,158,000.00
- CLNN $421,000.00
- Revenue This Year
- HYFM N/A
- CLNN N/A
- Revenue Next Year
- HYFM $3.93
- CLNN N/A
- P/E Ratio
- HYFM N/A
- CLNN N/A
- Revenue Growth
- HYFM N/A
- CLNN N/A
- 52 Week Low
- HYFM $0.43
- CLNN $3.82
- 52 Week High
- HYFM $1.20
- CLNN $11.00
- Technical
- Relative Strength Index (RSI)
- HYFM 48.16
- CLNN 44.03
- Support Level
- HYFM $0.55
- CLNN $4.75
- Resistance Level
- HYFM $0.60
- CLNN $5.06
- Average True Range (ATR)
- HYFM 0.05
- CLNN 0.37
- MACD
- HYFM -0.00
- CLNN -0.07
- Stochastic Oscillator
- HYFM 31.40
- CLNN 3.59
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).